| Added by | mollevi |
|---|---|
| Group name | EquipeCG |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Department of Medical Oncology, Nimes University Hospital, Nimes, France; nadine.houede@chu-nimes.fr. Clinical Research and Clinical Epidemiology Unit, Bergonie Cancer Institute, Bordeaux, France; Department of Oncology, Claudius Regaud Cancer Center, Toulouse, France; Department of Medical Oncology, Francois Baclesse Cancer Center, Caen, France; Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France; Department of Medical Oncology, CHD La Roche sur Yon, La Roche sur Yon, France; Alienor Farma, Parc Scientifique Unitec 1, Pessac, France; Centre Hospitalier de Pellegrin, Laboratoire de Pharmacologie et Toxicologie, Bordeaux, France; INSERM U862, Neurocentre Magendie, Bordeaux, France. alt-title: The oncologist number: 12 accession-num: 25355844 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 10:05:58 |
| Date Modified | 2018/07/20 - 10:05:58 |
| Parent item | A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer |
Institut de Recherche en Cancérologie de
